Matthew H G Katz
Overview
Explore the profile of Matthew H G Katz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
268
Citations
5323
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomita K, Maxwell J, Snyder R, Kim M, Tran Cao H, Tzeng C, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40045147
Central pancreatectomy (CP) is one of the parenchyma-sparing approaches proposed for low-grade tumors. CP has a lower incidence of diabetes compared with distal pancreatectomy, but may harbor risks of positive...
2.
Wang L, Li R, Wen A, Lu Q, Wang J, Ruan X, et al.
medRxiv
. 2025 Mar;
PMID: 40034771
Understanding the disease trajectories of specific diseases can provide important clinical insights. In this paper, we aimed to discover signature disease trajectories of 3 rare cancer types: pancreatic cancer, soft...
3.
Dekker E, van Klaveren D, Verkolf E, de Wilde R, Besselink M, OReilly E, et al.
Br J Surg
. 2025 Feb;
112(2).
PMID: 39967445
Background: Which patients with locally advanced pancreatic cancer may benefit from surgical exploration after induction treatment remains debated. The aim of this retrospective cohort study was to identify independent factors...
4.
Seo Y, Katz M, Snyder R
Ann Surg Oncol
. 2025 Jan;
32(4):2777-2785.
PMID: 39815074
Pancreatic cancer has a poor prognosis despite ongoing advances in systemic and multimodal therapies. This review analyzes recent progress and future directions in pancreatic cancer clinical trials, emphasizing the evolution...
5.
Cloyd J, Sarna A, Arango M, Bates S, Bhutani M, Bloomston M, et al.
JAMA Surg
. 2024 Dec;
160(2):172-180.
PMID: 39630427
Importance: Neoadjuvant therapy (NT) is an increasingly used treatment strategy for patients with localized pancreatic ductal adenocarcinoma (PDAC). Little research has been conducted on cancer care delivery during NT, and...
6.
Taherian M, Katz M, Prakash L, Wei D, Tong Y, Lai Z, et al.
Cancers (Basel)
. 2024 Oct;
16(19.
PMID: 39409932
Adequate sampling is essential to an accurate pathologic evaluation of pancreatectomy specimens resected for pancreatic ductal adenocarcinoma (PDAC) after neoadjuvant therapy (NAT). However, limited data are available for the association...
7.
Stoop T, Augustinus S, Bjornsson B, Tingstedt B, Andersson B, Wolfgang C, et al.
Ann Surg Oncol
. 2024 Oct;
31(13):8768-8769.
PMID: 39402315
No abstract available.
8.
Francescatti A, Hieken T, Katz M
Ann Surg Oncol
. 2024 Oct;
31(13):8476-8478.
PMID: 39361174
No abstract available.
9.
Torres M, Maxwell J, Snyder R, Tran Cao H, Kim M, Tzeng C, et al.
Ann Surg Oncol
. 2024 Sep;
31(13):8721-8722.
PMID: 39284994
Background: Robotic pancreatoduodenectomy is an increasingly accepted alternative for the treatment of pancreatic ductal adenocarcinoma (PDAC). However, the ability to perform a meticulous robotic-assisted superior mesenteric artery (SMA) dissection to...
10.
Habib J, Kinny-Koster B, Javed A, Zelga P, Saadat L, Kim R, et al.
J Clin Oncol
. 2024 Sep;
42(36):4317-4326.
PMID: 39255450
Purpose: The benefit of adjuvant therapy for intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) remains unclear because of severely limited evidence. Although biologically distinct entities, adjuvant therapy practices...